Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,107 | 1,005 | 982 | 951 | 988 |
| Accounts receivable | 101 | 134 | -289 | -53 | 3,309 |
| Other Working Capital | 735 | -394 | 2,198 | 350 | 638 |
| Other Operating Activity | -6,034 | -5,332 | -9,475 | -6,733 | -9,806 |
| Operating Cash Flow | $-4,091 | $-4,587 | $-6,584 | $-5,485 | $-4,871 |
| Cash Flows From Investing Activities | |||||
| Sale Of Investment | 0 | 0 | 0 | 0 | 45 |
| Purchase Sale Intangibles | 48 | -48 | 0 | -500 | N/A |
| Other Investing Activity | 0 | 769 | 0 | 0 | 0 |
| Investing Cash Flow | $48 | $721 | $0 | $-500 | $45 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -13 | -15 | 13 | -43 | -368 |
| Common Stock Issued | 0 | 0 | 0 | 38,341 | 8,735 |
| Other Financing Activity | 0 | 0 | -71 | 0 | 0 |
| Financing Cash Flow | $-13 | $-15 | $-58 | $38,298 | $8,368 |
| Beginning Cash Position | 39,315 | 43,197 | 49,839 | 17,525 | 13,941 |
| End Cash Position | 35,260 | 39,315 | 43,197 | 49,839 | 17,525 |
| Net Cash Flow | $-4,056 | $-3,881 | $-6,642 | $32,314 | $3,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,091 | -4,587 | -6,584 | -5,485 | -4,871 |
| Capital Expenditure | N/A | -48 | N/A | -500 | N/A |
| Free Cash Flow | -4,091 | -4,635 | -6,584 | -5,985 | -4,871 |